Frequencies for first 10,000 rows of drug4cl1 variable in nhamcsopd2004 dataset : drug class #1 for medication #4 | Freq. Percent Cum. ----------------------------------------+----------------------------------- anesthetics, unspecified | 1 0.01 0.01 anesthetics, local (injectable) | 24 0.24 0.25 anesthetics, general | 23 0.23 0.48 adjuncts to anesthesia/analeptics | 3 0.03 0.51 anesthetics, topical | 7 0.07 0.58 anesthetics, rectal | 1 0.01 0.59 antidotes, general | 1 0.01 0.60 antimicrobial agents, unspecified | 1 0.01 0.61 penicillins | 9 0.09 0.70 cephalosporins | 10 0.10 0.80 erythromycins/lincosamides/macrolides | 8 0.08 0.88 tetracyclines | 1 0.01 0.89 aminoglycosides | 2 0.02 0.91 sulfonamides and trimethoprim | 15 0.15 1.06 urinary tract antiseptics | 2 0.02 1.08 miscellaneous antibacterial agents | 7 0.07 1.15 antimycobacterial/anti-leprosy agents | 3 0.03 1.18 quinolones/derivatives | 10 0.10 1.28 antifungals | 5 0.05 1.33 antiviral agents | 26 0.26 1.59 deficiency anemias | 26 0.26 1.85 anticoagulants/thrombolytics | 19 0.19 2.04 cardiac glycosides | 10 0.10 2.14 antiarrhythmic agents | 1 0.01 2.15 antianginal agents | 11 0.11 2.26 vascular disorders, cerebral/peripheral | 3 0.03 2.29 antihypertensive agents | 54 0.54 2.83 diuretics | 53 0.53 3.36 relaxants/stimulants, urinary tract | 9 0.09 3.45 calcium channel blockers | 44 0.44 3.89 beta blockers | 38 0.38 4.27 alpha agonist/alpha blockers | 14 0.14 4.41 ace inhibitors | 71 0.71 5.12 sedatives and hypnotics | 29 0.29 5.41 antianxiety agents | 32 0.32 5.73 antipsychotic/antimanics | 33 0.33 6.06 antidepressants | 91 0.91 6.97 anorexiants/cns stimulants | 8 0.08 7.05 cns, miscellaneous | 5 0.05 7.10 alzheimer-type dementia | 2 0.02 7.12 antiemetics | 8 0.08 7.20 diagnostics, radiopaque & nonradioactiv | 1 0.01 7.21 disorders, acid/peptic | 82 0.82 8.03 antidiarrheals | 5 0.05 8.08 laxatives | 25 0.25 8.33 miscellaneous gastrointestinals | 5 0.05 8.38 antacids | 3 0.03 8.41 hyperlipidemia | 97 0.97 9.38 vitamins/minerals | 67 0.67 10.05 nutrition, enteral/parenteral | 4 0.04 10.09 repl/regs of electrolytes/water balance | 38 0.38 10.47 calcium metabolism | 8 0.08 10.55 hematopoietic growth factor | 2 0.02 10.57 adrenal corticosteroids | 26 0.26 10.83 androgens/anabolic steroids | 3 0.03 10.86 estrogens/progestins | 9 0.09 10.95 blood glucose regulators | 79 0.79 11.74 thyroid/antithyroid | 24 0.24 11.98 contraceptives | 5 0.05 12.03 vaccines/antisera | 70 0.70 12.73 immunomodulators | 9 0.09 12.82 antiseptics/disinfectants | 2 0.02 12.84 dermatologics, misc. | 18 0.18 13.02 keratolytics | 1 0.01 13.03 topical steroids | 11 0.11 13.14 burn/sunburn, sunscreen/suntan products | 1 0.01 13.15 acne products | 2 0.02 13.17 topical anti-infectives | 5 0.05 13.22 anorectal products | 1 0.01 13.23 topical analgesics | 6 0.06 13.29 extrapyramidal movement disorders | 10 0.10 13.39 skeletal muscle hyperactivity | 16 0.16 13.55 anticonvulsants | 55 0.55 14.10 antineoplastics, miscellaneous | 11 0.11 14.21 hormonal/biological response mod. | 6 0.06 14.27 antimetabolites | 5 0.05 14.32 dna damaging drugs | 11 0.11 14.43 glaucoma | 2 0.02 14.45 ocular anti-infective/anti-inflammatory | 2 0.02 14.47 miscellaneous ophthalmics | 1 0.01 14.48 otic, topical (misc) | 1 0.01 14.49 vertigo/motion sickness/vomiting | 20 0.20 14.69 analgesics/general | 2 0.02 14.71 analgesics, narcotic | 70 0.70 15.41 analgesics, non-narcotic | 108 1.08 16.49 antimigraine/other headaches | 3 0.03 16.52 antiarthritics | 16 0.16 16.68 antigout | 1 0.01 16.69 nsaid | 48 0.48 17.17 antiprotozoals | 7 0.07 17.24 antimalarials | 4 0.04 17.28 respiratory tract drugs, unspecified | 2 0.02 17.30 antiasthmatics/bronchodilators | 52 0.52 17.82 nasal decongestants | 3 0.03 17.85 antitussives/expectorants/mucolytics | 10 0.10 17.95 antihistamines | 37 0.37 18.32 cold remedies | 1 0.01 18.33 corticosteroid-inhalation/nasal | 15 0.15 18.48 miscellaneous/unclassified | 1 0.01 18.49 unclassified | 20 0.20 18.69 pharmaceutical aids | 3 0.03 18.72 surgical aids | 1 0.01 18.73 homeopathic products | 6 0.06 18.79 . | 8,121 81.21 100.00 ----------------------------------------+----------------------------------- Total | 10,000 100.00 by Jean Roth , jroth@nber.org , 28 Mar 2016